Clinical Trial Update: Twin SUBLIVAC® Grasses Clinical Efficacy Study [Phase 3]

View source ↗

Summary

Phase 3 clinical efficacy study of Twin SUBLIVAC Grasses for seasonal allergic rhinitis and allergic conjunctivitis. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis
• Seasonal Allergic Rhinitis

Drugs mentioned

• Twin SUBLIVAC Grasses

Snippet

Sponsor: HAL Allergy | Conditions: Rhinitis, Allergic, Seasonal, Conjunctivitis, Allergic | Phase 3 | Status: COMPLETED